Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
The World Health Organization (WHO) estimates that 8.5 million people across the globe are affected by Parkinson’s. For many of them, hypomimia—a loss or reduction of facial expressions—is one of the most difficult aspects of the neurological disease, putting up barriers to a significant form of communication.
To provide better tools to navigate hypomimia, Brazilian-based multinational pharmaceutical corporation Eurofarma has launched a project called Scrolling Therapy. Developed by agency Dentsu Creative and supported by the Brazil Parkinson Association, the app helps Parkinson’s patients slow the progression of their symptoms while performing an everyday activity of scrolling social media.
Scrolling
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in